Siristatidis CS - Search Results

1

Aspirin is not recommended for women undergoing IVF.

Siristatidis CS, Dodd SR, Drakeley AJ. Siristatidis CS, et al. Hum Reprod Update. 2012 May-Jun;18(3):233. doi: 10.1093/humupd/dmr049. Epub 2012 Jan 18. Hum Reprod Update. 2012. PMID: 22258759 Review. No abstract available.

2

Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.

Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET. Siristatidis C, et al. Hum Reprod Update. 2013 Mar-Apr;19(2):105-23. doi: 10.1093/humupd/dms051. Epub 2012 Dec 18. Hum Reprod Update. 2013. PMID: 23255514 Review.

3

Addition of prednisolone and heparin in patients with failed IVF/ICSI cycles: a preliminary report of a clinical trial.

Siristatidis C, Chrelias C, Creatsa M, Varounis C, Vrachnis N, Iliodromiti Z, Kassanos D. Siristatidis C, et al. Hum Fertil (Camb). 2013 Sep;16(3):207-10. doi: 10.3109/14647273.2013.803608. Epub 2013 Jul 8. Hum Fertil (Camb). 2013. PMID: 23834353 Clinical Trial.

4

The practical role of anti-Müllerian hormone in assisted reproduction.

Siristatidis C, Trivella M, Chrelias C, Vrachnis N, Drakeley A, Kassanos D. Siristatidis C, et al. Clin Exp Obstet Gynecol. 2013;40(4):482-4. Clin Exp Obstet Gynecol. 2013. PMID: 24597238 Review.

5

Aspirin for in vitro fertilisation.

Siristatidis CS, Basios G, Pergialiotis V, Vogiatzi P. Siristatidis CS, et al. Cochrane Database Syst Rev. 2016 Nov 3;11(11):CD004832. doi: 10.1002/14651858.CD004832.pub4. Cochrane Database Syst Rev. 2016. PMID: 27807847 Free PMC article. Review.

6

Endometrial injury for RIF patients undergoing IVF/ICSI: a prospective nonrandomized controlled trial.

Siristatidis C, Kreatsa M, Koutlaki N, Galazios G, Pergialiotis V, Papantoniou N. Siristatidis C, et al. Gynecol Endocrinol. 2017 Apr;33(4):297-300. doi: 10.1080/09513590.2016.1255325. Epub 2016 Dec 2. Gynecol Endocrinol. 2017. PMID: 27910711 Clinical Trial.

7

Mild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF/ICSI: a case-control study.

Siristatidis C, Dafopoulos K, Vrantza T, Salamalekis G, Basios G, Vogiatzi P, Pergialiotis V, Papantoniou N. Siristatidis C, et al. Gynecol Endocrinol. 2017 Jul;33(7):553-556. doi: 10.1080/09513590.2017.1296128. Epub 2017 Mar 3. Gynecol Endocrinol. 2017. PMID: 28277113

8

Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.

Siristatidis CS, Sertedaki E, Vaidakis D. Siristatidis CS, et al. Cochrane Database Syst Rev. 2017 May 23;5(5):CD011872. doi: 10.1002/14651858.CD011872.pub2. Cochrane Database Syst Rev. 2017. PMID: 28534597 Free PMC article. Updated. Review.

9

Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.

Siristatidis CS, Sertedaki E, Vaidakis D, Varounis C, Trivella M. Siristatidis CS, et al. Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011872. doi: 10.1002/14651858.CD011872.pub3. Cochrane Database Syst Rev. 2018. PMID: 29547689 Free PMC article. Review.

10

In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.

Siristatidis CS, Maheshwari A, Vaidakis D, Bhattacharya S. Siristatidis CS, et al. Cochrane Database Syst Rev. 2018 Nov 15;11(11):CD006606. doi: 10.1002/14651858.CD006606.pub4. Cochrane Database Syst Rev. 2018. PMID: 30480769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page